Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Steroid cell tumors in the ovary are rare, can produce testosterone causing symptoms, and are mainly treated with surgery.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Hormones and genes affect hair growth and male baldness.

Sex hormones do not cause oral lichen planus.

Oral lichen planus is not linked to sex hormone levels.

SHBG may be a useful early indicator and treatment target for PCOS.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.